| Literature DB >> 35601257 |
Craig W Maynard1,2, Michael T Kidd1, Peter V Chrystal2,3, Leon R McQuade4, Bernie V McInerney4, Peter H Selle2,5, Sonia Y Liu2,3.
Abstract
As lowering crude protein (CP) in poultry diets continues to minimize amino acid excess, it is important to understand the limiting order of amino acids and the impact of their deficiencies. Therefore, a pair of experiments were conducted to observe the effects of individual amino acid deletions on growth performance, carcass traits, and nutrient utilization. Both experiments involved 3 control diets based on wheat and soybean meal, including a 210.0 g/kg CP industry control (IC), 186.7 g/kg CP positive control (PC) supplemented with feed-grade amino acids to match the IC amino acid profile, 186.7 g/kg CP negative control (NC) with reducing N corrected apparent metabolizable energy (AMEN) by 0.5 MJ/kg and removing feed-grade amino acids beyond L-Lys-HCl, DL-Met, and L-Thr from PC. Ten deletion diets where the following supplemented amino acids were individually removed from the PC: Val, Ile, Leu, Trp, Arg, His, Phe + Tyr, glycine equivalence (Glyequi), Pro, and Energy (0.5 MJ/kg reduction in AMEN of the PC). All diets were formulated to contain similar concentrations of digestible Lys, total sulfur amino acid (TSAA) and Thr. Experimental diets were offered to broiler chickens from 15 to 22 d post-hatch in a cage study (Exp. 1) to gain digestibility and nutrient utilization data; whereas they were offered from 15 to 35 d post-hatch in a floor-pen study (Exp. 2) to gain performance and carcass yield data. The removal of supplemented Val, Arg, and Ile resulted in reduction on broiler performance (P < 0.05), and the removal of Val, Arg, Ile, and Glyequi negatively influenced carcass traits (P < 0.05). Results from both experiments indicate that Val and Arg are co-limiting in wheat-soybean meal diets, but that Ile and Glyequi may potentially limit breast and thigh development.Entities:
Keywords: Amino acid; Broiler chicken; Crude protein; Low protein diet
Year: 2022 PMID: 35601257 PMCID: PMC9111891 DOI: 10.1016/j.aninu.2021.11.010
Source DB: PubMed Journal: Anim Nutr ISSN: 2405-6383
Composition of experimental diets fed during the periods in both experiments containing various commercial amino acid supplementation1.
| Item | IC | PC | NC | Val | Ile | Leu | Trp | Arg | His | Phe + Tyr | Glyequi | Pro | Energy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingredients, g/kg as-fed | |||||||||||||
| Wheat | 584.6 | 641.7 | 641.7 | 641.7 | 641.7 | 641.7 | 641.7 | 641.7 | 641.7 | 641.7 | 641.7 | 641.7 | 641.7 |
| Canola seed | 40.0 | 40.0 | 40.0 | 40.0 | 40.0 | 40.0 | 40.0 | 40.0 | 40.0 | 40.0 | 40.0 | 40.0 | 40.0 |
| Soybean meal | 286.6 | 164.5 | 164.5 | 164.5 | 164.5 | 164.5 | 164.5 | 164.5 | 164.5 | 164.5 | 164.5 | 164.5 | 164.5 |
| Soy oil | 34.7 | 37.4 | 24.8 | 37.4 | 37.4 | 37.4 | 37.4 | 37.4 | 37.4 | 37.4 | 37.4 | 37.4 | 24.8 |
| L-LysHCl | 2.7 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 |
| DL-Met | 2.9 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 |
| L-Thr | 1.3 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 |
| L-Val | 0.0 | 2.2 | 0.0 | 0.0 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 |
| L-Arg | 0.0 | 3.6 | 0.0 | 3.6 | 3.6 | 3.6 | 3.6 | 0.0 | 3.6 | 3.6 | 3.6 | 3.6 | 3.6 |
| L-Ile | 0.0 | 2.1 | 0.0 | 2.1 | 0.0 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 |
| L-Leu | 0.0 | 3.5 | 0.0 | 3.5 | 3.5 | 0.0 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 | 3.5 |
| L-His | 0.0 | 1.2 | 0.0 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 0.0 | 1.2 | 1.2 | 1.2 | 1.2 |
| Gly | 0.0 | 1.8 | 0.0 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 0.0 | 1.8 | 1.8 |
| L-Ser | 0.0 | 2.2 | 0.0 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 0.0 | 2.2 | 2.2 |
| L-Trp | 0.0 | 0.6 | 0.0 | 0.6 | 0.6 | 0.6 | 0.0 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 |
| L-Phe | 0.0 | 2.3 | 0.0 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 0.0 | 2.3 | 2.3 | 2.3 |
| L-Tyr | 0.0 | 1.7 | 0.0 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 0.0 | 1.7 | 1.7 | 1.7 |
| L-Pro | 0.0 | 2.0 | 0.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 0.0 | 2.0 |
| L-Glu | 0.0 | 0.0 | 38.4 | 2.8 | 2.4 | 3.9 | 0.9 | 12.2 | 3.5 | 3.5 | 6.7 | 2.6 | 0.0 |
| NaCl | 2.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| NaHCO3 | 0.8 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 |
| KHCO3 | 0.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 |
| Limestone | 8.9 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 |
| CaHPO4 | 10.9 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 | 12.6 |
| Enzyme blend | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Choline chloride | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| Celite | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 |
| Inert filler | 1.0 | 28.6 | 26.1 | 28.0 | 28.3 | 28.1 | 28.3 | 20.0 | 26.3 | 29.2 | 25.9 | 28.0 | 41.2 |
| Premix | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 |
| Calculated composition, g/kg unless noted otherwise | |||||||||||||
| AMEN, MJ/kg | 12.90 | 12.90 | 12.40 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.40 |
| CP | 210.0 | 186.7 | 186.7 | 186.7 | 186.7 | 186.7 | 186.7 | 186.7 | 186.7 | 186.7 | 186.7 | 186.7 | 186.7 |
| Ca | 8.3 | 8.3 | 8.3 | 8.3 | 8.3 | 8.3 | 8.3 | 8.3 | 8.3 | 8.3 | 8.3 | 8.3 | 8.3 |
| Available P | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 |
| Na | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 |
| Cl | 2.7 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 |
| K | 9.3 | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 |
| DEB, mEq/kg | 240 | 230 | 230 | 230 | 230 | 230 | 230 | 230 | 230 | 230 | 230 | 230 | 230 |
| Digestible Lys | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 | 11.5 |
| Digestible TSAA | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 |
| Digestible Met | 5.6 | 6.1 | 6.1 | 6.1 | 6.1 | 6.1 | 6.1 | 6.1 | 6.1 | 6.1 | 6.1 | 6.1 | 6.1 |
| Digestible Cys | 3.1 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 |
| Digestible Thr | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 | 7.7 |
| Digestible Val | 8.7 | 8.7 | 6.5 | 6.5 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 | 8.7 |
| Digestible Ile | 8.0 | 8.0 | 5.9 | 8.0 | 5.9 | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 | 8.0 |
| Digestible Leu | 13.9 | 13.9 | 10.4 | 13.9 | 13.9 | 10.4 | 13.9 | 13.9 | 13.9 | 13.9 | 13.9 | 13.9 | 13.9 |
| Digestible Arg | 12.3 | 12.3 | 8.7 | 12.3 | 12.3 | 12.3 | 12.3 | 8.7 | 12.3 | 12.3 | 12.3 | 12.3 | 12.3 |
| Digestible Trp | 2.5 | 2.5 | 1.9 | 2.5 | 2.5 | 2.5 | 1.9 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
| Digestible Phe | 9.2 | 9.2 | 6.9 | 9.2 | 9.2 | 9.2 | 9.2 | 9.2 | 9.2 | 6.9 | 9.2 | 9.2 | 9.2 |
| Digestible Tyr | 6.5 | 6.5 | 4.8 | 6.5 | 6.5 | 6.5 | 6.5 | 6.5 | 6.5 | 4.8 | 6.5 | 6.5 | 6.5 |
| Digestible Phe + Tyr | 15.8 | 15.8 | 11.7 | 15.8 | 15.8 | 15.8 | 15.8 | 15.8 | 15.8 | 11.7 | 15.8 | 15.8 | 15.8 |
| Digestible Gly | 7.5 | 7.5 | 5.7 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 5.7 | 7.5 | 7.5 |
| Digestible Ser | 9.0 | 9.0 | 6.8 | 9.0 | 9.0 | 9.0 | 9.0 | 9.0 | 9.0 | 9.0 | 6.8 | 9.0 | 9.0 |
| Digestible Glyequi | 13.9 | 13.9 | 10.5 | 13.9 | 13.9 | 13.9 | 13.9 | 13.9 | 13.9 | 13.9 | 10.5 | 13.9 | 13.9 |
| Digestible His | 4.8 | 4.8 | 3.6 | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 | 3.6 | 4.8 | 4.8 | 4.8 | 4.8 |
| Digestible Pro | 13.3 | 13.3 | 11.3 | 13.3 | 13.3 | 13.3 | 13.3 | 13.3 | 13.3 | 13.3 | 13.3 | 11.3 | 13.3 |
| Analyzed composition, g/kg | |||||||||||||
| CP | 230.2 | 204.3 | 218.3 | 206.5 | 214.5 | 212.5 | 199.0 | 207.5 | 228.0 | 206.6 | 210.2 | 213.5 | 232.8 |
| Total Lys | 12.7 | 11.1 | 13.6 | 12.5 | 12.2 | 13.3 | 11.2 | 12.4 | 11.2 | 12.2 | 11.8 | 13.5 | 13.5 |
| Total Met | 4.1 | 4.4 | 5.3 | 5.1 | 4.9 | 5.2 | 4.7 | 5.0 | 4.8 | 4.8 | 4.7 | 5.4 | 4.8 |
| Total Thr | 9.0 | 8.0 | 8.9 | 8.7 | 8.5 | 8.9 | 8.0 | 8.5 | 8.1 | 8.4 | 8.2 | 8.7 | 9.2 |
| Total Val | 10.4 | 9.7 | 8.3 | 8.1 | 10.1 | 10.4 | 9.6 | 10.0 | 9.7 | 9.9 | 10.0 | 10.4 | 11.1 |
| Total Ile | 9.4 | 8.5 | 7.4 | 8.8 | 7.1 | 9.0 | 8.4 | 8.8 | 8.5 | 8.7 | 8.6 | 8.9 | 9.7 |
| Total Leu | 16.3 | 15.3 | 12.9 | 15.6 | 15.6 | 12.8 | 15.1 | 15.6 | 15.2 | 15.5 | 15.4 | 15.7 | 17.2 |
| Total Arg | 12.8 | 11.6 | 9.9 | 12.4 | 12.3 | 13.1 | 11.7 | 9.3 | 11.9 | 12.2 | 12.1 | 13.0 | 14.0 |
| Total Phe + Tyr | 15.2 | 14.3 | 12.2 | 14.8 | 14.7 | 15.4 | 14.5 | 14.9 | 14.6 | 11.6 | 14.7 | 15.0 | 16.5 |
| Total Phe | 10.7 | 10.1 | 8.5 | 10.3 | 10.3 | 10.6 | 10.0 | 10.4 | 10.1 | 8.2 | 10.2 | 10.3 | 11.3 |
| Total Tyr | 4.5 | 4.2 | 3.6 | 4.5 | 4.4 | 4.8 | 4.5 | 4.5 | 4.5 | 3.4 | 4.5 | 4.7 | 5.2 |
| Total Gly | 9.1 | 8.1 | 7.2 | 8.7 | 8.7 | 8.9 | 8.1 | 8.6 | 8.2 | 8.5 | 6.9 | 9.2 | 9.5 |
| Total Ser | 10.8 | 9.7 | 8.7 | 10.1 | 10.2 | 10.4 | 9.6 | 10.1 | 9.8 | 10.0 | 8.3 | 10.3 | 11.0 |
| Total His | 5.6 | 5.2 | 4.5 | 5.3 | 5.3 | 5.5 | 5.2 | 5.4 | 4.3 | 5.3 | 5.3 | 5.4 | 5.9 |
| Total Pro | 15.1 | 14.8 | 13.1 | 15.0 | 15.0 | 14.9 | 14.7 | 14.9 | 15.0 | 14.7 | 14.8 | 12.7 | 15.2 |
| Total Glu | 49.1 | 41.7 | 81.3 | 47.1 | 44.6 | 45.5 | 42.0 | 52.9 | 44.5 | 44.1 | 47.0 | 43.4 | 43.7 |
| Total Asp | 19.0 | 12.9 | 13.8 | 13.3 | 12.9 | 13.5 | 12.5 | 12.9 | 12.7 | 12.9 | 13.0 | 13.2 | 16.1 |
| Total Ala | 8.6 | 6.4 | 6.6 | 6.4 | 6.3 | 6.5 | 6.2 | 6.3 | 6.3 | 6.3 | 6.4 | 6.4 | 7.4 |
| PDI, % | 82.60 | 84.03 | 93.93 | 83.33 | 84.40 | 83.37 | 87.90 | 85.47 | 81.87 | 79.93 | 81.90 | 82.53 | 91.63 |
Glyequi = glycine equivalence; PDI = pellet durability index.
Dietary treatments included 3 control diets with industry control (IC), positive control (PC), and negative control (NC). Subsequent 9 diets were identified by their deleted amino acid 3-letter codes. The ‘Energy’ diet was created by reducing the energy content of the PC by 0.5 MJ/kg. Treatment means represented average of 6 replicate cages.
The enzyme blend contained (per kilogram of diet): phytase, 1,000 FTU; xylanase, 4,000 BXU.
Celite served as a source of acid insoluble ash to provide an inert internal dietary marker to determine amino acid digestibility coefficients (World Minerals Inc, Lompoc, CA).
Washed builder's sand.
The premix provided per kilogram of complete feed: retinol, 12,000 IU; cholecalciferol, 5,000 IU; tocopherol, 50 mg; menadione, 3 mg; thiamine, 3 mg; riboflavin, 9 mg; pyridoxine, 5 mg; cobalamin, 0.025 mg; niacin, 50 mg; pantothenate, 18 mg; folate, 2 mg; biotin, 0.2 mg; copper, 20 mg; iron, 40 mg; manganese, 110 mg; cobalt, 0.25 mg; iodine, 1 mg; molybdenum, 2 mg; zinc, 90 mg; selenium, 0.3 mg.
Effect of CP reduction and feed-grade amino acid supplementation on the calculated amino acid concentration of the industry control (IC), positive control (PC), and negative control (NC) diets.
| Item | Ratio to Lys, % | Relative to PC, % | Relative to requirement | ||||||
|---|---|---|---|---|---|---|---|---|---|
| IC | PC | NC | IC | PC | NC | IC | PC | NC | |
| Lys | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| TSAA | 76 | 76 | 76 | 100 | 100 | 100 | 105 | 105 | 105 |
| Met | 49 | 53 | 53 | 92 | 100 | 100 | 122 | 133 | 133 |
| Cys | 27 | 22 | 22 | 119 | 100 | 100 | 84 | 70 | 70 |
| Thr | 67 | 67 | 67 | 100 | 100 | 100 | 100 | 100 | 100 |
| Val | 76 | 76 | 57 | 100 | 100 | 75 | 98 | 98 | 73 |
| Ile | 70 | 70 | 51 | 100 | 100 | 74 | 104 | 104 | 77 |
| Leu | 121 | 121 | 90 | 100 | 100 | 75 | 111 | 111 | 83 |
| Trp | 22 | 22 | 17 | 100 | 100 | 76 | 128 | 128 | 97 |
| Arg | 107 | 107 | 76 | 100 | 100 | 71 | 102 | 102 | 72 |
| His | 42 | 42 | 31 | 100 | 100 | 75 | 119 | 119 | 89 |
| Phe + Tyr | 137 | 137 | 102 | 100 | 100 | 75 | 130 | 130 | 97 |
| Phe | 80 | 80 | 60 | 100 | 100 | 75 | 133 | 133 | 100 |
| Tyr | 57 | 57 | 42 | 100 | 100 | 74 | 126 | 126 | 93 |
| Glyequi | 121 | 121 | 92 | 100 | 100 | 76 | 54 | 54 | 41 |
| Gly | 65 | 65 | 50 | 100 | 100 | 76 | 37 | 37 | 28 |
| Ser | 78 | 78 | 59 | 100 | 100 | 76 | 113 | 113 | 86 |
| Pro | 116 | 116 | 98 | 100 | 100 | 85 | 63 | 63 | 53 |
Digestible basis.
Requirement estimates adapted from Wu (2014) (ratio to digestible Lys, 11.5 g/kg): Lys, 100; Met, 40; Cys, 32; Thr, 67; Val, 77; Ile, 67; Leu, 109; Trp, 17; Arg, 105; His, 35; Phe, 60; Tyr, 45; Gly, 176; Ser, 69; Pro, 184.
Sum of Phe and Tyr.
Glycine equivalent calculated according to the equation reported by Siegert et al. (2015b).
Live performance of Ross 308 males fed experimental diets from 15 to 22 d in Exp. 1.
| Item | BW gain, kg | Feed intake, kg | FCR, g:g | Mortality, % |
|---|---|---|---|---|
| Treatment | ||||
| IC | 0.788abc | 0.966cde | 1.226a | 0.00 |
| PC | 0.771bcd | 0.964de | 1.253abc | 0.00 |
| NC | 0.707ef | 0.957ef | 1.354f | 0.00 |
| Val | 0.682f | 0.924f | 1.357f | 0.00 |
| Ile | 0.740de | 0.971bcde | 1.315e | 0.00 |
| Leu | 0.807ab | 1.001abc | 1.242ab | 4.17 |
| Trp | 0.739de | 1.005ab | 1.361f | 0.00 |
| Arg | 0.706ef | 0.962de | 1.365f | 0.00 |
| His | 0.752cd | 0.968bcde | 1.288de | 0.00 |
| Phe + Tyr | 0.806ab | 0.993abcde | 1.232a | 0.00 |
| Glyequi | 0.796ab | 1.008a | 1.267bcd | 0.00 |
| Pro | 0.782abc | 0.995abcd | 1.274cd | 0.00 |
| Energy | 0.814a | 1.005ab | 1.237a | 4.17 |
| SEM | 0.0160 | 0.0135 | 0.0104 | 1.634 |
| <0.001 | <0.001 | <0.001 | 0.537 | |
BW = body weight; FCR = feed conversion ratio (feed:gain ratio); Glyequi = glycine equivalence.
a-f Within a column, means without a common superscript were determined to be significantly different (P < 0.05) by a student's t-test.
Dietary treatments included 3 control diets with industry control (IC), positive control (PC), and negative control (NC). Subsequent 9 diets are identified by their deleted amino acid 3-letter codes. The ‘Energy’ diet was created by reducing the energy content of the PC by 0.5 MJ/kg. Treatment means represent average of 6 replicate cages.
Live performance of Ross 308 males fed experimental diets from 15 to 35 d in Exp. 2.
| Item | BW gain, kg | Feed intake, kg | FCR, g:g | Mortality, % |
|---|---|---|---|---|
| Treatment | ||||
| IC | 2.195bc | 2.954bc | 1.344abc | 0.00 |
| PC | 2.244ab | 2.998abc | 1.334a | 1.39 |
| NC | 2.018d | 2.936c | 1.455e | 0.00 |
| Val | 1.872e | 2.631d | 1.415d | 4.17 |
| Ile | 2.138c | 2.947c | 1.379c | 0.00 |
| Leu | 2.227ab | 2.979abc | 1.338ab | 0.00 |
| Trp | 2.248ab | 2.993abc | 1.340ab | 2.78 |
| Arg | 2.047d | 2.939c | 1.443de | 1.39 |
| His | 2.223ab | 2.960bc | 1.343abc | 2.78 |
| Phe + Tyr | 2.253ab | 3.076a | 1.374bc | 1.39 |
| Glyequi | 2.259ab | 3.027abc | 1.351abc | 2.78 |
| Pro | 2.254ab | 3.076a | 1.364abc | 0.00 |
| Energy | 2.281a | 3.059ab | 1.341ab | 0.00 |
| SEM | 0.0281 | 0.0379 | 0.0129 | 1.334 |
| <0.001 | <0.001 | <0.001 | 0.326 | |
BW = body weight; FCR = feed conversion ratio (feed:gain ratio); Glyequi = glycine equivalence.
a-e Within a column, means without a common superscript were determined to be significantly different (P < 0.05) by a student's t-test.
Dietary treatments included 3 control diets with industry control (IC), positive control (PC), and negative control (NC). Subsequent 9 diets are identified by their deleted amino acid 3-letter codes. Treatment means represent average of 6 replicate pens. The ‘Energy’ diet was created by reducing the energy content of the PC by 0.5 MJ/kg. Treatment means represent average of 6 replicate cages.
Carcass traits of Ross 308 males fed diets varying in amino acid and energy supplementation from 15 to 35 d in Exp. 2.
| Item | Parts weights | Parts yields | ||||
|---|---|---|---|---|---|---|
| Total breast, kg | Thigh, kg | Fat, kg | Total breast, g/kg | Thigh, g/kg | Fat, g/kg | |
| Treatment | ||||||
| IC | 0.621a | 0.162ab | 0.025b | 226.7abc | 59.3bcde | 9.0e |
| PC | 0.637a | 0.163ab | 0.028ab | 233.6a | 59.9abcd | 10.3cde |
| NC | 0.525bc | 0.146cd | 0.030a | 211.4e | 59.0cde | 12.1ab |
| Val | 0.514c | 0.145cd | 0.025b | 219.9cd | 61.9a | 10.7bcd |
| Ile | 0.561b | 0.156bc | 0.027ab | 213.1de | 59.1bcde | 10.4cde |
| Leu | 0.632a | 0.164ab | 0.027ab | 228.5ab | 59.5bcde | 9.8cde |
| Trp | 0.629a | 0.163ab | 0.026ab | 230.7ab | 59.9abcde | 9.4de |
| Arg | 0.531bc | 0.143d | 0.030a | 216.3de | 58.1de | 12.2a |
| His | 0.612a | 0.162ab | 0.030a | 229.1ab | 60.5abc | 11.2abc |
| Phe + Tyr | 0.620a | 0.162ab | 0.027ab | 227.4abc | 59.1bcde | 10.0cde |
| Glyequi | 0.618a | 0.159ab | 0.029ab | 225.2bc | 57.7e | 10.5cd |
| Pro | 0.613a | 0.161ab | 0.027ab | 227.3abc | 59.6bcde | 10.1cde |
| Energy | 0.628a | 0.168a | 0.018c | 229.7ab | 61.3ab | 6.5f |
| SEM | 0.0133 | 0.0039 | 0.0016 | 2.91 | 0.79 | 0.49 |
| <0.001 | <0.001 | <0.001 | <0.001 | 0.029 | <0.001 | |
Glyequi = glycine equivalence.
a-f Within a column, means without a common superscript were determined to be significantly different (P < 0.05) by a student's t-test.
Yields expressed relative to live body weight. Total breast yield representative of Pectoralis major + P. minor. Thigh representative of bone-in, skin-on right thigh.
Dietary treatments included 3 control diets with industry control (IC), positive control (PC), and negative control (NC). Subsequent 9 diets are identified by their deleted amino acid 3-letter codes. The ‘Energy’ diet was created by reducing the energy content of the PC by 0.5 MJ/kg. Treatment means represent average of 5 replicate cages.
Nutrient utilization and excreta dry matter of Ross 308 males fed diets varying in amino acid and energy supplementation 15 to 22 d in Exp. 1.
| Item | AME, MJ/kg | ME:GE ratio, MJ/MJ | N retention, g:g | AMEN, MJ/kg | Excreta dry matter, g/kg |
|---|---|---|---|---|---|
| Treatment | |||||
| IC | 12.76b | 0.726bc | 0.663de | 11.87cd | 217.6c |
| PC | 13.23ab | 0.770a | 0.732ab | 12.35ab | 258.7cd |
| NC | 12.78b | 0.772a | 0.653d | 11.95b | 286.4abc |
| Val | 11.94c | 0.713b | 0.676c | 11.13c | 306.3a |
| Ile | 13.31ab | 0.783a | 0.697c | 12.43ab | 287.4abc |
| Leu | 13.39ab | 0.790a | 0.742a | 12.46ab | 275.6abc |
| Trp | 13.80a | 0.815a | 0.682c | 13.01a | 266.4bc |
| Arg | 13.66a | 0.799a | 0.683c | 12.83a | 263.0c |
| His | 13.39ab | 0.783a | 0.745a | 12.39ab | 265.6c |
| Phe + Tyr | 13.65a | 0.810a | 0.727ab | 12.77a | 300.9ab |
| Glyequi | 13.70a | 0.802a | 0.719b | 12.81a | 262.9c |
| Pro | 13.20ab | 0.794a | 0.730ab | 12.29ab | 282.6abc |
| Energy | 13.17ab | 0.799a | 0.694c | 12.23ab | 224.8d |
| SEM | 0.281 | 0.0167 | 0.0073 | 0.282 | 12.18 |
| 0.002 | 0.010 | <0.001 | 0.002 | 0.002 | |
AME = apparent metabolizable energy; ME:GE ratio = metabolizable energy to gross energy ratio; N retention = nitrogen retention; AMEN = nitrogen corrected apparent metabolizable energy; Glyequi = glycine equivalence.
a-e Within a column, means without a common superscript were determined to be significantly different (P < 0.05) by a student's t-test.
Dietary treatments included 3 control diets with positive control (PC) and negative control (NC). Subsequent 9 diets are identified by their deleted amino acid 3-letter codes. Treatment means represent average of six replicate cages. The ‘Energy’ diet was created by reducing the energy content of the PC by 0.5 MJ/kg.
Apparent digestibility coefficients and disappearance rates of protein in the distal jejunum and distal ileum of Ross 308 males fed diets varying in amino acid and energy supplementation 15 to 22 d in Exp. 1.
| Item | Digestibility coefficients | Disappearance rates | ||
|---|---|---|---|---|
| Distal jejunum | Distal ileum | Distal jejunum | Distal ileum | |
| Treatment | ||||
| PC | 0.784a | 0.872a | 19.07abcd | 21.21cd |
| NC | 0.766ab | 0.850abc | 20.13ab | 22.34bc |
| Val | 0.705bcde | 0.839bcd | 16.44e | 19.56e |
| Ile | 0.690de | 0.840bcd | 17.88cde | 21.77c |
| Leu | 0.694cde | 0.843bc | 17.84cde | 21.68c |
| Trp | 0.699bcde | 0.814de | 17.45cde | 20.31de |
| Arg | 0.692cde | 0.828cde | 17.64cde | 21.12cd |
| His | 0.740abcd | 0.846abc | 20.37ab | 23.34ab |
| Phe + Tyr | 0.758abc | 0.858ab | 19.43abc | 21.97c |
| Glyequi | 0.706bcde | 0.848abc | 18.38bcde | 22.03bc |
| Pro | 0.655e | 0.810e | 17.34de | 21.39cd |
| Energy | 0.718abcde | 0.845bc | 20.93a | 24.63a |
| SEM | 0.0240 | 0.0092 | 0.725 | 0.476 |
| 0.014 | 0.001 | 0.001 | <0.001 | |
Glyequi = glycine equivalence.
a-e Within a column, means without a common superscript were determined to be significantly different (P < 0.05) by a student's t-test.
Disappearance rates reflect cumulative disappearance rate for the identified intestinal section.
Dietary treatments included 3 control diets with positive control (PC) and negative control (NC). Subsequent 9 diets are identified by their deleted amino acid 3-letter codes. The ‘Energy’ diet was created by reducing the energy content of the PC by 0.5 MJ/kg. Treatment means represent average of 6 replicate cages.
Plasma essential amino acid concentrations (μg/mL) of Ross 308 males fed diets varying in amino acid and energy supplementation from 15 to 35 d in Exp. 2.
| Item | Lys | Met | Thr | Val | Ile | Leu | Trp | Arg | Phe | His |
|---|---|---|---|---|---|---|---|---|---|---|
| Treatment | ||||||||||
| IC | 25.7def | 13.7e | 72.3e | 21.0b | 10.1b | 17.5bcd | 4.7 | 65.2abc | 15.4ce | 11.7de |
| PC | 18.9ef | 14.7de | 80.3cde | 17.4c | 7.0ef | 15.0cde | 4.9 | 46.0e | 16.4bc | 7.5fg |
| NC | 55.3a | 19.6bc | 164.1b | 20.0bc | 8.7bcde | 17.3bcd | 4.5 | 15.8f | 13.3d | 5.8g |
| Val | 32.1cd | 20.0b | 94.5cd | 12.1d | 9.7bc | 18.5bc | 5.0 | 65.8ab | 17.3bc | 17.1b |
| Ile | 24.9def | 19.3bc | 94.1cd | 21.8b | 5.4f | 19.3b | 5.1 | 67.2a | 18.8ab | 15.7bc |
| Leu | 20.5ef | 17.2bcd | 88.6cde | 32.2a | 15.0a | 11.5e | 4.7 | 54.9cde | 16.9bc | 9.7ef |
| Trp | 29.7cde | 18.4bc | 92.0cde | 20.4bc | 8.5bcde | 17.1bcd | 4.1 | 57.1abcd | 17.2bc | 11.3de |
| Arg | 46.1a | 23.6a | 185.9a | 32.0a | 13.6a | 24.6a | 5.3 | 15.7f | 20.1a | 23.2a |
| His | 26.5cdef | 17.6bcd | 83.7cde | 18.8bc | 7.9cde | 15.8bcd | 4.5 | 56.2bcde | 15.0cd | 5.0g |
| Phe + Tyr | 17.7f | 16.5cde | 96.1c | 19.8bc | 8.4bcde | 17.4bcd | 4.2 | 53.4de | 13.1d | 13.3cd |
| Glyequi | 19.1ef | 17.6bcd | 71.5e | 18.8bc | 7.5de | 16.6bcd | 4.5 | 54.8de | 16.2c | 10.7def |
| Pro | 24.3def | 16.8cde | 83.7cde | 18.3bc | 7.3ef | 14.7de | 4.8 | 57.8abcd | 15.4cd | 12.1de |
| Energy | 37.3bc | 15.2de | 73.0de | 21.3b | 9.4bcd | 16.5bcd | 5.0 | 65.8ab | 15.2cd | 13.2cd |
| SEM | 4.08 | 1.11 | 7.67 | 1.25 | 0.70 | 1.27 | 0.30 | 3.69 | 0.86 | 1.22 |
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.266 | <0.001 | <0.001 | <0.001 | |
Glyequi = glycine equivalence.
a-g Within a column, means without a common superscript were determined to be significantly different (P < 0.05) by a student's t-test.
Dietary treatments included 3 control diets with industry control (IC), positive control (PC), and negative control (NC). Subsequent 9 diets are identified by their deleted amino acid 3-letter codes. The ‘Energy’ diet was created by reducing the energy content of the PC by 0.5 MJ/kg. Treatment means represent average of 2 replicate cages.
Plasma conditionally essential, sparing, and non-essential amino acid concentrations (μg/mL) of Ross 308 males fed diets varying in amino acid and energy supplementation from 15 to 35 d in Exp. 2.
| Item | Conditional | Sparing | Non-essential | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gly | Pro | Cys | Tyr | Ser | Ala | Asn | Asp | Gln | Glu | |
| Treatment | ||||||||||
| IC | 46.0cd | 49.8bc | 15.5bc | 28.6fg | 46.9d | 52.1d | 15.5bc | 16.4 | 138.7cd | 22.7c |
| PC | 44.4d | 42.5c | 14.3cd | 36.9bcde | 49.8cd | 48.3d | 8.7c | 12.9 | 137.9cd | 20.1c |
| NC | 55.4b | 65.9a | 17.8a | 24.7gh | 61.6b | 138.2a | 22.5ab | 16.7 | 203.0a | 32.2a |
| Val | 50.6bcd | 54.8b | 16.2b | 36.4bcde | 53.3bcd | 52.1d | 7.2c | 14.8 | 144.0bcd | 20.4c |
| Ile | 52.4bc | 54.1b | 15.7bc | 38.5bcd | 56.3bc | 50.2d | 12.4c | 15.4 | 149.3bcd | 22.3c |
| Leu | 47.6cd | 54.6b | 14.5cd | 43.7ab | 52.0cd | 68.3c | 13.5c | 15.3 | 169.9b | 23.1c |
| Trp | 48.8bcd | 48.9bc | 15.4bc | 40.9abc | 51.3cd | 53.4cd | 7.6c | 15.7 | 148.7bcd | 22.0c |
| Arg | 76.4a | 74.9a | 18.4a | 47.7a | 89.2a | 119.4b | 26.3a | 14.9 | 217.7a | 27.4b |
| His | 48.3bcd | 45.5bc | 15.1bcd | 32.5def | 49.2cd | 48.8d | 10.2c | 12.7 | 139.5cd | 19.5c |
| Phe + Tyr | 51.8bcd | 53.7b | 14.5cd | 19.9h | 52.1cd | 57.0cd | 10.8c | 17.2 | 163.2bc | 22.6c |
| Glyequi | 34.0e | 48.8bc | 13.8d | 38.2bcd | 38.1e | 60.5cd | 9.2c | 13.8 | 147.3bcd | 21.2c |
| Pro | 47.6bcd | 41.5c | 14.9bcd | 34.9cdef | 51.1ce | 49.7d | 8.4c | 13.9 | 150.3bcd | 20.8c |
| Energy | 48.2bcd | 46.5bc | 14.6bcd | 30.6efg | 50.6ce | 48.0d | 6.9c | 15.0 | 125.4d | 20.0c |
| SEM | 2.77 | 3.92 | 0.57 | 2.65 | 3.04 | 5.50 | 3.17 | 1.89 | 9.49 | 1.31 |
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.886 | <0.001 | <0.001 | |
Glyequi = glycine equivalence.
a-g Within a column, means without a common superscript were determined to be significantly different (P < 0.05) by a student's t-test.
Dietary treatments included 3 control diets with industry control (IC), positive control (PC), and negative control (NC). Subsequent 9 diets are identified by their deleted amino acid 3-letter codes. The ‘Energy’ diet was created by reducing the energy content of the PC by 0.5 MJ/kg. Treatment means represent average of 2 replicate cages.